Psychometric validation of the insomnia severity index in adults with sickle cell disease

Gyasi Moscou-Jackson, Jerilyn Allen, Michael T. Smith, Carlton Haywood

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Background. The Insomnia Severity Index (ISI) is an instrument to evaluate insomnia symptoms. The psychometric properties have not been established in adults (18 years of age or older) with sickle cell disease (SCD). Objective. Evaluate the reliability and validity of the ISI among adults with SCD. Methods. Analysis included psychometric evaluation with exploratory factor analysis. Results. Our 263 participants had a mean age of 35.6 years and primarily were female (54.8%) with HbSS genotype (69.2%). Almost 41% were classified as clinical insomnia cases (ISI ≥14) using the traditional scoring approach. Two factors, Insomnia Symptoms and Insomnia Impact, emerged during factor analysis. Reliability of both factor- scales was good and each correlated with pain severity and depressive symptomatology (r = 0.38 to 0.66, p<.01). Conclusion. The ISI demonstrated construct validity and reliability for evaluating insomnia symptomatology among adults with SCD and can be used in research and clinical practice.

Original languageEnglish (US)
Pages (from-to)209-218
Number of pages10
JournalJournal of health care for the poor and underserved
Issue number1
StatePublished - Feb 2016


  • Anemia
  • Factor analysis
  • Questionnaires
  • Sickle cell
  • Statistical
  • Validation studies

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Psychometric validation of the insomnia severity index in adults with sickle cell disease'. Together they form a unique fingerprint.

Cite this